Potential of Tahongai leaf extracts (Kleinhovia Hospital.) in handling vaginal discharge caused candida albicans: laboratory study
Journal Title: International Journal of Allied Medical Sciences and Clinical Research - Year 2019, Vol 7, Issue 1
Abstract
Background Candida Albicans is the main causative pathogenic microorganism with a recurrence rate of 40-45% causing disruption of the female reproductive organs and conventional discomfort and treatment causing various side effects and resistance. For this reason, it is necessary to conduct research to prove herbal ingredients as a potential alternative treatment in cases of pathological vaginal discharge that are expected to contribute to midwifery services. Objective To aim the potential of effective extracts of tahongai leaves able to inhibit candida albicans in vitro, as well as the duration of the inhibitory power of more than 24 hours. Method True experimental post-test only control group design, subjects used candida albicans isolates from vaginal patients with the Mc Farland standard suspension 0.5. The inhibitory test uses the disk diffusion method using Fluconazole control. Results There are influences of inhibition of various concentrations namely 0.39%, 0.78%, 1.56%, 3.125%, 6.25%, 12.5%, 25%, 50%, 75%, 100% of candida albicans with ANOVA statistical tests (p_value<0.05 ) The post-hoc test results showed that the concentration of effective extract was 100% with Fluconazole having a inhibition power not different or the same as the p value = 0.999 (> 0.05) because the average strength of the delay was not far adrift. The old ability of extract inhibition also exceeds 24 hours, which is 48 hours with 72 hours indicating the same inhibition power than before. So, the future opportunity to use tahongai leaf extract clinically can be used once a day for vaginal discharge. Conclusions and Recommendations The effective 100% concentration of tahongai leaf extract has the potential as an alternative ingredient for vaginal discharge caused by albicans candida. next study preclinical test Potential of tahongai leaf extract Tahongai leaf extract (Kleinhoviahospita L.) to the inhibition of candida albicans with experimental animal subjects. So that the results of research can be applied to humans as an alternative treatment for vaginal discharge in providing midwifery care to reproductive health services for women of childbearing age
Authors and Affiliations
Ni WayanEti Parwati
Keywords
Related Articles
- EP ID EP535931
- DOI -
- Views 42
- Downloads 0
Added effect of therapist made low cost flutter device for airway clearance in acute exacerbation of COPD
The purpose of the study is to determine the added effect of therapist made low cost flutter device for airway clearance in acute exacerbation of COPD and to identify whether there is any difference in the amount of expe...
An unusual presentation of IVC thrombosis- Low backache
Inferior vena cava thrombosis (IVCT) is less common than deep venous thrombosis of the lower extremities, particularly in the absence of an obvious congenital abnormality. IVCT is an uncommon and under recognized conditi...
In vitro activity of mupirocin on staphylococcal nasal carriers among health care providers of post operative surgical ward in a tertiary care hospital
Methicillin-resistant Staphylococcus aureus (MRSA) has been associated with considerable morbidity and mortality and is an important public health issue. It is an opportunistic pathogen. The increasing resistance of this...
Comparision of nerve flossing and conventional therapy with only conventional therapy for sciatica
Background Sciatica is one of the most common painful and disabling conditions affecting about 40% of low back pain cases and 1.6% - 43% of adult population annually. Many conventional physiotherapeutic modalities have b...
Design and characterization of pentoxifyllinepharmacosomes by solvent evaporation method
Aim The objective of the present investigation is to formulate the Pentoxifyllinepharmacosomes using 32 factorial design technique. Methods Pentoxifylline is drug of choice for treatment of patients with intermittent cla...